Kilitch Drugs (India) Ltd.
172.40+0.0 (+0.01%)
26 Aug, 12:00 AM
Analyst Ratings and Targets
Kilitch Drugs (India) Ltd. analyst ratings, buy/sell/hold recommendations and 12-month price targets from leading brokerages.
Analyst Ratings
Seems like this stock doesn't have any active recommendations by analyst.
Target Price
Current market price
₹ 172.40
Median target price
₹ 232.00 (34.57%)
Highest target price
₹ 232.00 (34.57%)
Average target price
₹ 232.00 (34.57%)
Lowest target price
₹ 232.00 (34.57%)
Financial Estimates
Kilitch Drugs (India) Ltd. analyst consensus estimates for revenue, EBITDA, PAT and EPS (consolidated) for the next 2 financial years on a rolling basis.
This stock doesn't have any active financial estimates by analysts, or consolidated estimates are not available.
Estimates Revision
How Kilitch Drugs (India) Ltd. analyst consensus for revenue and earnings has been revised over the last 12 months.
EPS revisions in the last 12 months
EPS estimate for FY end:
Mar 2027
Frequently Asked Questions
What is the analyst consensus recommendation for Kilitch Drugs (India) Ltd.?
The analyst consensus recommendation for Kilitch Drugs (India) Ltd. can be found in the Analyst Ratings section. It aggregates buy, hold and sell ratings from brokerages covering the stock.
What is the target price for Kilitch Drugs (India) Ltd.?
The median analyst target price for Kilitch Drugs (India) Ltd. is ₹ 232.00, with a high target of ₹ 232.00 and a low target of ₹ 232.00. The mean (average) target is ₹ 232.00.
How many analysts cover Kilitch Drugs (India) Ltd.?
The number of analysts actively covering Kilitch Drugs (India) Ltd. is displayed in the Analyst Ratings section of the Forecast tab, including their buy, hold and sell breakdown.
What is the upside or downside potential for Kilitch Drugs (India) Ltd. from the current price?
Based on the current market price of ₹ 172.40 and the median analyst target of ₹ 232.00, there is a 34.6% upside potential for Kilitch Drugs (India) Ltd. according to analyst consensus.
What is the revenue estimate for Kilitch Drugs (India) Ltd. for the next financial year?
Analyst consensus revenue estimates for Kilitch Drugs (India) Ltd. for the next one to two financial years are available in the Financial Estimates section of the Forecast tab.
What is the EPS estimate for Kilitch Drugs (India) Ltd.?
The current trailing twelve month EPS of Kilitch Drugs (India) Ltd. is 8.72. Forward EPS estimates from analyst consensus are available in the Financial Estimates section.
What is the BPS estimate for Kilitch Drugs (India) Ltd.?
Book Value Per Share (BPS) estimates for Kilitch Drugs (India) Ltd. from analyst consensus are available in the Financial Estimates section of the Forecast tab. BPS reflects the net asset value per share and is used to gauge price-to-book valuation.
Are analysts bullish or bearish on Kilitch Drugs (India) Ltd.?
Analyst sentiment on Kilitch Drugs (India) Ltd. is reflected through the buy/hold/sell distribution shown in the Analyst Ratings section. The consensus outlook is updated as brokerages revise their ratings.
Has the analyst consensus for Kilitch Drugs (India) Ltd. been revised recently?
Estimate revision history for Kilitch Drugs (India) Ltd. is available in the Estimates Revision section of the Forecast tab, showing how analyst consensus for revenue and earnings has changed over the past 12 months.
What is the current PE ratio of Kilitch Drugs (India) Ltd. compared to the target implied PE?
The current trailing PE of Kilitch Drugs (India) Ltd. is 20.71. Based on the median analyst target price of ₹ 232.00 and TTM EPS of 8.72, the target-implied forward PE is approximately 26.6x.